Febuxostat versus allopurinol for gout. [N Engl J Med. 2006]

Febuxostat versus allopurinol for gout. [N Engl J Med. 2006]
Febuxostat versus allopurinol for gout.
Lustberg ME. N Engl J Med. 2006 Apr 6; 354(14):1532-3; author reply 1532-3.
Review Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout. [Clin Ther. 2009]
Review Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.
Ernst ME, Fravel MA. Clin Ther. 2009 Nov; 31(11):2503-18.
Febuxostat--treatment for hyperuricemia and gout? [N Engl J Med. 2005]
Febuxostat--treatment for hyperuricemia and gout?
Moreland LW. N Engl J Med. 2005 Dec 8; 353(23):2505-7.
Febuxostat compared with allopurinol in patients with hyperuricemia and gout. [N Engl J Med. 2005]
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N. N Engl J Med. 2005 Dec 8; 353(23):2450-61.
Review Febuxostat (Uloric) for chronic treatment of gout. [Med Lett Drugs Ther. 2009]
Review Febuxostat (Uloric) for chronic treatment of gout.
. Med Lett Drugs Ther. 2009 May 18; 51(1312):37-8.

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout. [Core Evid. 2010]
Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout.
Gaffo AL, Saag KG. Core Evid. 2010 Jun 15; 4:25-36. Epub 2010 Jun 15.
The role of urate and xanthine oxidase in vascular oxidative stress: future directions. [Ther Clin Risk Manag. 2009]
The role of urate and xanthine oxidase in vascular oxidative stress: future directions.
George J, Struthers A. Ther Clin Risk Manag. 2009; 5:799-803. Epub 2009 Oct 12.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Febuxostat versus allopurinol for gout.
Febuxostat versus allopurinol for gout.
N Engl J Med. 2006 Apr 6 ;354(14):1532-3; author reply 1532-3.

PubMed
Effect of rheumatoid arthritis upon other members of the family.
Effect of rheumatoid arthritis upon other members of the family.
Clin Rheumatol. 1992 Jun ;11(2):185-8.

PubMed
Epidemiology of HIV in China.
Epidemiology of HIV in China.
BMJ. 2002 Apr 6 ;324(7341):803-4.

PubMed
Black-white mortality differences by family income.
Black-white mortality differences by family income.
Lancet. 1992 Aug 8 ;340(8815):346-50.

PubMed
Add-on or step-up trials for new drug development in rheumatoid arthritis: a new...
Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?
Arthritis Rheum. 2003 Jun ;48(6):1481-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed